OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Webinar on Cancer Biomarker
Cancer Biomarker Webinar

OriGene TissueScan in recent publications
Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis J. Natl. Cancer Inst. Apr 2015 [Tissues]

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

DNA (5 µg); Prostate; Hyperplasia of prostate

Specifications Related Products Research Agreement FAQs
Catalog No. Description Price Shipping
CD563071 DNA (5 µg); Prostate; Hyperplasia of prostate $ 209 3 days
<< Back to Search Result   Add to Shopping Cart
Disease StateOther Disease
Diagnosis CategoryBenign prostatic hyperplasia (BPH)
TissueProstate
Case IDCU0000001131
PrepA
Vial IDDN0000140D
Frozen Sample IDFR00003BBE
Tissue of OriginProstate
Site of FindingProstate
AppearanceLesional
Sample Diagnosis (from Pathology Verification)Hyperplasia of prostate
Normal55%
Lesional45%
Tumor0%
Tumor Hypo/Acellular Stroma0%
Tumor Hypercellular Stroma0%
Necrosis0%
Pathology Verification notes from H&E review45% Glandular epithelium, 55% Fibromuscular stroma. Contains benign prostate hyperplasia
Bioanalyzer Ratio (28S/18S)1.99
CASE Diagnosis (from medical center path report)Hyperplasia of prostate
Age76
GenderMale
Race
Tumor Grade
Minimum Stage Grouping
T (Extent of Primary Tumor)
N (Lymph node metastasis)
M (Distant metastasis)
Diagnostic Test Results

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title